• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲氨蝶呤在眼科的临床应用及副作用综述

A Review of Clinical Applications and Side Effects of Methotrexate in Ophthalmology.

作者信息

Wang Ge, Peng Xiaoyan

机构信息

Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Science Key Lab, Beijing, China.

出版信息

J Ophthalmol. 2020 Aug 11;2020:1537689. doi: 10.1155/2020/1537689. eCollection 2020.

DOI:10.1155/2020/1537689
PMID:32850138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7439192/
Abstract

Methotrexate (MTX) is a folate analog widely used against a range of diseases including malignancies and autoimmune disorders. Its high effectiveness-price ratio also won extensive application in ophthalmology. On the other hand, although MTX has an excellent pharmacological efficacy, MTX associated side effects in clinical use, which vary from patient to patient, are nonnegligible. There is no comparatively systematic review on MTX associated side effects and its risk factors. This review aimed to reveal novel clinical approaches of MTX and its adverse effects in order to provide a reference for ophthalmic scholars in clinical application of MTX.

摘要

甲氨蝶呤(MTX)是一种叶酸类似物,广泛用于治疗包括恶性肿瘤和自身免疫性疾病在内的一系列疾病。其高效价比也使其在眼科领域得到广泛应用。另一方面,尽管MTX具有出色的药理功效,但MTX在临床使用中出现的副作用因人而异,不容忽视。目前尚无关于MTX相关副作用及其危险因素的较为系统的综述。本综述旨在揭示MTX的新临床应用方法及其不良反应,为眼科学者在MTX临床应用中提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f3/7439192/cab885bdca74/JOPH2020-1537689.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f3/7439192/cab885bdca74/JOPH2020-1537689.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1f3/7439192/cab885bdca74/JOPH2020-1537689.001.jpg

相似文献

1
A Review of Clinical Applications and Side Effects of Methotrexate in Ophthalmology.甲氨蝶呤在眼科的临床应用及副作用综述
J Ophthalmol. 2020 Aug 11;2020:1537689. doi: 10.1155/2020/1537689. eCollection 2020.
2
Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review.甲氨蝶呤治疗类风湿关节炎的副作用:系统评价。
Eur J Med Chem. 2018 Oct 5;158:502-516. doi: 10.1016/j.ejmech.2018.09.027. Epub 2018 Sep 13.
3
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.阿达木单抗联合甲氨蝶呤治疗与幼年特发性关节炎相关的难治性葡萄膜炎:一项 RCT。
Health Technol Assess. 2019 Apr;23(15):1-140. doi: 10.3310/hta23150.
4
Methotrexate for treating rheumatoid arthritis.甲氨蝶呤用于治疗类风湿关节炎。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD000957. doi: 10.1002/14651858.CD000957.pub2.
5
Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis: A Systematic Review.叶酸补充剂治疗类风湿关节炎患者甲氨蝶呤治疗:系统评价。
J Clin Rheumatol. 2019 Aug;25(5):197-202. doi: 10.1097/RHU.0000000000000810.
6
The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis.类风湿关节炎中叶酸转运体-1基因80G/A多态性与甲氨蝶呤疗效或甲氨蝶呤相关毒性之间的关联:一项荟萃分析。
Int Immunopharmacol. 2016 Sep;38:8-15. doi: 10.1016/j.intimp.2016.05.012. Epub 2016 May 24.
7
Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.叶酸代谢途径中遗传多态性对风湿性疾病中甲氨蝶呤治疗的影响。
Pharmacogenomics. 2011 Oct;12(10):1449-63. doi: 10.2217/pgs.11.86.
8
Mitochondrial dysfunction and oxidative stress are involved in the mechanism of methotrexate-induced renal injury and electrolytes imbalance.线粒体功能障碍和氧化应激与甲氨蝶呤诱导的肾损伤和电解质失衡的机制有关。
Biomed Pharmacother. 2018 Nov;107:834-840. doi: 10.1016/j.biopha.2018.08.050. Epub 2018 Aug 22.
9
A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.一种无载体的叶酸受体靶向熊果酸/甲氨蝶呤纳米递药系统用于协同抗癌治疗。
Int J Nanomedicine. 2021 Mar 3;16:1775-1787. doi: 10.2147/IJN.S287806. eCollection 2021.
10
Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.在具有与转运相关的甲氨蝶呤抗性的人白血病CCRF-CEM细胞中鉴定一种膜相关叶酸结合蛋白。
Cancer Res. 1989 May 1;49(9):2455-9.

引用本文的文献

1
Acute accidental methotrexate poisoning: Fatal consequences - An Indian experience.急性意外甲氨蝶呤中毒:致命后果——印度的经验
Indian J Pharmacol. 2025 May 1;57(3):196-199. doi: 10.4103/ijp.ijp_363_24. Epub 2025 Jul 9.
2
Tolerability and Efficacy of Topical Methotrexate in Ocular Surface Disease.局部用甲氨蝶呤治疗眼表疾病的耐受性和疗效
Cureus. 2025 Mar 21;17(3):e80958. doi: 10.7759/cureus.80958. eCollection 2025 Mar.
3
Topical Therapy in Psoriasis: Clinical Benefits, Advances in Novel Drug Delivery Strategies, and Gene Therapy Regimen.

本文引用的文献

1
[Methotrexate in juvenile idiopathic arthritis. Adverse effects and associated factors].[甲氨蝶呤用于青少年特发性关节炎。不良反应及相关因素]
An Pediatr (Engl Ed). 2020 Mar;92(3):124-131. doi: 10.1016/j.anpedi.2019.05.010. Epub 2019 Nov 4.
2
Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases.甲氨蝶呤与吗替麦考酚酯单药治疗非感染性眼部炎症性疾病的疗效比较。
Am J Ophthalmol. 2019 Dec;208:68-75. doi: 10.1016/j.ajo.2019.07.008. Epub 2019 Jul 22.
3
The effect of leucovorin rescue therapy on methotrexate-induced oral mucositis in the treatment of paediatric ALL: A systematic review.
银屑病的局部治疗:临床益处、新型药物递送策略的进展及基因治疗方案
Pharmaceutics. 2025 Feb 20;17(3):283. doi: 10.3390/pharmaceutics17030283.
4
Efficacy and safety of methotrexate in the treatment of proliferative vitreoretinopathy: a systematic review.甲氨蝶呤治疗增殖性玻璃体视网膜病变的疗效与安全性:一项系统评价
Eye (Lond). 2025 Feb;39(3):460-467. doi: 10.1038/s41433-024-03503-5. Epub 2024 Dec 14.
5
Evaluating the docetaxel effect in an animal model of polyarthritis.评估多关节炎动物模型中的多西紫杉醇疗效。
Inflammopharmacology. 2024 Jun;32(3):1827-1838. doi: 10.1007/s10787-024-01459-2. Epub 2024 Apr 15.
6
(Burm.f.) Nees Alleviates Methotrexate-Induced Hepatotoxicity in Wistar Albino Rats.(缅甸种)内斯减轻甲氨蝶呤诱导的Wistar白化大鼠肝毒性。
Life (Basel). 2023 May 12;13(5):1173. doi: 10.3390/life13051173.
7
Punicalagin Protects against the Development of Methotrexate-Induced Hepatotoxicity in Mice via Activating Nrf2 Signaling and Decreasing Oxidative Stress, Inflammation, and Cell Death.鞣花酸通过激活 Nrf2 信号通路和降低氧化应激、炎症和细胞死亡来预防甲氨蝶呤诱导的小鼠肝毒性。
Int J Mol Sci. 2022 Oct 15;23(20):12334. doi: 10.3390/ijms232012334.
8
Methotrexate plus reduced or full-dose glucocorticoids for the treatment of active, moderate-to-severe Graves' orbitopathy.甲氨蝶呤联合减量或全量糖皮质激素治疗活动期、中重度格雷夫斯眼眶病。
Eur Thyroid J. 2022 Aug 24;11(5). doi: 10.1530/ETJ-22-0017. Print 2022 Oct 1.
9
Beneficial role of naringin against methotrexate-induced injury to rat testes: biochemical and ultrastructural analyses.柚皮苷对甲氨蝶呤诱导的大鼠睾丸损伤的保护作用:生化和超微结构分析。
Redox Rep. 2022 Dec;27(1):158-166. doi: 10.1080/13510002.2022.2101832.
10
Intracameral Injection of Methotrexate for Treatment of Epithelial Ingrowth.前房内注射甲氨蝶呤治疗上皮植入
J Curr Ophthalmol. 2022 Apr 16;34(1):115-117. doi: 10.4103/JOCO.JOCO_159_21. eCollection 2022 Jan-Mar.
亚叶酸钙解救疗法对儿童急性淋巴细胞白血病治疗中氨甲喋呤诱导的口腔黏膜炎的作用:系统评价。
Crit Rev Oncol Hematol. 2019 Oct;142:1-8. doi: 10.1016/j.critrevonc.2019.07.003. Epub 2019 Jul 9.
4
Intracranial Methotrexate-Associated Lymphoproliferative Disorder in Rheumatoid Arthritis.颅内甲氨蝶呤相关性淋巴组织增生性疾病与类风湿关节炎。
World Neurosurg. 2019 Oct;130:138-141. doi: 10.1016/j.wneu.2019.06.226. Epub 2019 Jul 8.
5
Optimising low-dose methotrexate for rheumatoid arthritis-A review.优化治疗类风湿关节炎的低剂量甲氨蝶呤:综述。
Br J Clin Pharmacol. 2019 Oct;85(10):2228-2234. doi: 10.1111/bcp.14057. Epub 2019 Aug 9.
6
Intravitreal Methotrexate for Recurrent Epithelial Downgrowth.玻璃体内注射甲氨蝶呤治疗复发性上皮内生
JAMA Ophthalmol. 2019 Sep 1;137(9):1082-1083. doi: 10.1001/jamaophthalmol.2019.2151.
7
Fetal methotrexate syndrome: A systematic review of case reports.胎儿氨甲蝶呤综合征:病例报告的系统评价。
Reprod Toxicol. 2019 Aug;87:125-139. doi: 10.1016/j.reprotox.2019.05.066. Epub 2019 Jun 8.
8
The effect of asparaginase therapy on methotrexate toxicity and efficacy in children with acute lymphoblastic leukemia. asparaginase 治疗对儿童急性淋巴细胞白血病中甲氨蝶呤毒性和疗效的影响。
Leuk Lymphoma. 2019 Dec;60(12):3002-3010. doi: 10.1080/10428194.2019.1613537. Epub 2019 May 23.
9
Methotrexate disposition, anti-folate activity and efficacy in the collagen-induced arthritis mouse model.甲氨蝶呤处置、抗叶酸活性和疗效在胶原诱导性关节炎小鼠模型中的作用。
Eur J Pharmacol. 2019 Jun 15;853:264-274. doi: 10.1016/j.ejphar.2019.03.052. Epub 2019 Apr 2.
10
New therapies in development for the management of non-infectious uveitis: A review.正在开发的用于治疗非感染性葡萄膜炎的新疗法:综述。
Clin Exp Ophthalmol. 2019 Apr;47(3):396-417. doi: 10.1111/ceo.13511.